Neutrophils Require SHP1 To Regulate IL-1β Production and Prevent Inflammatory Skin Disease

被引:37
作者
Croker, Ben A. [1 ,2 ,3 ]
Lewis, Rowena S. [1 ]
Babon, Jeff J. [1 ,2 ,4 ]
Mintern, Justine D. [5 ]
Jenne, Dieter E. [6 ]
Metcalf, Donald [1 ,2 ]
Zhang, Jian-Guo [1 ]
Cengia, Louise H. [1 ]
O'Donnell, Joanne A. [1 ]
Roberts, Andrew W. [1 ,2 ,7 ]
机构
[1] Walter & Eliza Hall Inst Med Res, Canc & Haematol Div, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia
[3] Scripps Res Inst, Dept Genet, La Jolla, CA 92037 USA
[4] Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic 3052, Australia
[5] Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3052, Australia
[6] Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Martinsried, Germany
[7] Univ Melbourne, Fac Med, Parkville, Vic 3010, Australia
基金
英国医学研究理事会; 美国国家卫生研究院; 澳大利亚国家健康与医学研究理事会; 澳大利亚研究理事会;
关键词
MOTH-EATEN MICE; NECROSIS-FACTOR-ALPHA; TYROSINE-PHOSPHATASE; GENE-EXPRESSION; RESPIRATORY BURST; INFLUENZA-VIRUS; CELL LYMPHOMA; DEATH DOMAIN; MUTANT MICE; NPM-ALK;
D O I
10.4049/jimmunol.1002702
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The regulation of neutrophil recruitment, activation, and disposal is pivotal for circumscribed inflammation. SHP1(Y208N/Y208N) mutant mice develop severe cutaneous inflammatory disease that is IL-1R dependent. Genetic reduction in neutrophil numbers and neutrophilic responses to infection is sufficient to prevent the spontaneous initiation of this disease. Neutrophils from SHP1(Y208N/Y208N) mice display increased pro-IL-1 beta production due to altered responses to MyD88-dependent and MyD88-independent signals. The IL-1R-dependent inflammatory disease in SHP1(Y208N/Y208N) mice develops independently of caspase 1 and proteinase 3 and neutrophil elastase. In response to Fas ligand, a caspase 1-independent inducer of IL-1 beta production, neutrophils from SHP1(Y208N/Y208N) mice produce elevated levels of IL-1 beta but display reduced caspase 3 and caspase 7 activation. In neutrophils deficient in SHP1, IL-1 beta induces high levels of pro-IL-1 beta suggesting the presence of a paracrine IL-1 beta loop. These data indicate that the neutrophil-and IL-1-dependent disease in SHP1(Y208N/Y208N) mice is a consequence of loss of negative regulation of TLR and IL-1R signaling. The Journal of Immunology, 2011, 186: 1131-1139.
引用
收藏
页码:1131 / 1139
页数:9
相关论文
共 41 条
[31]  
Oka T, 2002, CANCER RES, V62, P6390
[32]   Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias: Combination analysis with cDNA expression array and tissue microarray [J].
Oka, T ;
Yoshino, T ;
Hayashi, K ;
Ohara, N ;
Nakanishi, T ;
Yamaai, Y ;
Hiraki, A ;
Sogawa, CA ;
Kondo, E ;
Teramoto, N ;
Takahashi, K ;
Tsuchiyama, J ;
Akagi, T .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (04) :1495-1505
[33]   How neutrophils kill microbes [J].
Segal, AW .
ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 :197-223
[34]  
SHULTZ LD, 1984, AM J PATHOL, V116, P179
[35]   MUTATIONS AT THE MURINE MOTH-EATEN LOCUS ARE WITHIN THE HEMATOPOIETIC-CELL PROTEIN-TYROSINE-PHOSPHATASE (HCPH) GENE [J].
SHULTZ, LD ;
SCHWEITZER, PA ;
RAJAN, TV ;
YI, TL ;
IHLE, JN ;
MATTHEWS, RJ ;
THOMAS, ML ;
BEIER, DR .
CELL, 1993, 73 (07) :1445-1454
[36]  
Tapley P, 1997, EXP HEMATOL, V25, P122
[37]   The Intracellular Sensor NLRP3 Mediates Key Innate and Healing Responses to Influenza A Virus via the Regulation of Caspase-1 [J].
Thomas, Paul G. ;
Dash, Pradyot ;
Aldridge, Jerry R., Jr. ;
Ellebedy, Ali H. ;
Reynolds, Cory ;
Funk, Amy J. ;
Martin, William J. ;
Lamkanfi, Mohamed ;
Webby, Richard J. ;
Boyd, Kelli L. ;
Doherty, Peter C. ;
Kanneganti, Thirumala-Devi .
IMMUNITY, 2009, 30 (04) :566-575
[38]  
Thrall RS, 1997, AM J PATHOL, V151, P1303
[39]  
TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124
[40]   B and T cells are not required for the viable motheaten phenotype [J].
Yu, CCK ;
Tsui, HW ;
Ngan, BY ;
Shulman, MJ ;
Wu, GE ;
Tsui, FWL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) :371-380